Drugs use in the students, unemployed and active working of 18-25 years old
Tendances n° 62, OFDT, 4 p.
There are many surveys and studies on drug use in adolescents or pupils in secondary schools, as drug use likely to continue into adulthood begins in adolescence. Contrastingly, such surveys and studies are fewer in students in higher education: this is a population for which no national sampling frame exists and for whom there are fewer opportunities to question the individuals than in secondary schools.
The few student surveys reveal particularly widespread use of alcohol, tobacco and cannabis in this group although these studies have a relatively low participation rate and do not enable a comparison between these students and other populations.
Adult population representative inquiries enable us to get around this difficulty by offering large samples containing a sufficiently large number of students to be able to perform a valid statistical analysis. They also provide a control population of similar age which is not present in surveys limited to students.
This issue of Tendances describes the use of psychoactive substances by students, the unemployed and those in active work in the 18-25 age group in France in 2005 and compares the three groups against each other: it also describes a few changes since 2000.
Stéphane Legleye, François Beck, Patrick Peretti-Watel, Nearkasen Chau
Download the PDF file (125 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.
Country drug reports
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.